Herein, we demonstrate that cancer stem cells (CSCs) play a pivotal role in suppressing CD103<sup>+</sup> T cell differentiation in patients with non-small cell lung cancer (NSCLC). The gene discussed is ITGAE; the disease is non-small cell lung carcinoma.